Tag Archives: COVID-19 vaccine

COVID-19 vaccine considerations for multiemployer plan sponsors

Following the issuance of the emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) of the Pfizer-BioNTech and Moderna COVID-19 vaccines, plan sponsors need to consider how to cover the administration of the COVID-19 vaccines for their memberships. 

In addition to vaccine administration coverage, plan sponsors have been faced with other decisions relating to COVID-19 throughout 2020, and have taken various approaches to addressing issues resulting from the pandemic. 

At this point, the expectation is that the federal government will pick up the cost of the vaccine itself for nongovernmental plans. Coverage for the cost of administration of the vaccine will depend on the grandfathered status of the plan.  

In this Multiemployer Alert, Milliman’s Michael HalfordSean Silva, and David Stoddard provide plan administrators with information they should consider as 2020 comes to a close.